We are live on ! Find out more
PAVM icon

PAVmed
PAVM

73 hedge funds and large institutions have $11.5M invested in PAVmed in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 28 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $154K | Put options by funds: $90K

0.02% less ownership

Funds ownership: 0.05% → 0.03% (-0.02%)

22% less funds holding

Funds holding: 94 → 73 (-21)

57% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 30

58% less capital invested

Capital invested by funds: $27M → $11.5M (-$15.6M)

64% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 28

Holders
73
Holders Change
-21
Holders Change %
-22.34%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
10
Reduced
28
Closed
30
Calls
$154K
Puts
$90K
Net Calls
+$64K
Net Calls Change
+$60K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.7M
2
E
Ergoteles
New York
+$384K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$68.6K
4
Verition Fund Management
Verition Fund Management
Connecticut
+$41.1K
5
Citadel Advisors
Citadel Advisors
Florida
+$37.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.52M
2
State Street
State Street
Massachusetts
-$1.26M
3
N
Nuveen
North Carolina
-$874K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$808K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$792K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
101
Aquatic Capital Management
Illinois
– -$3K -6 Closed
1 2 3 4
5

PAVM Hedge Fund Activity: Q2 2022 in Review

73 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2022, worth a combined $11.5M — down 58% from $27M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of PAVM and 13 opened new positions — a net loss of 17 holders — while 28 trimmed existing stakes and 10 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.7M. The largest seller was BlackRock, cutting an estimated $3.52M.

  • 73 institutional investors held PAVmed (PAVM) as of Q2 2022, down from 94 in Q1 2022.
  • Funds reported $11.5M of PAVmed stock for Q2 2022, down 58% quarter-over-quarter.
  • 13 funds opened new PAVmed positions in Q2 2022 and 30 closed out, a net change of -17 holders.
  • The largest PAVmed buyer in Q2 2022 was Millennium Management, an estimated $1.7M added.
  • The largest PAVmed seller in Q2 2022 was BlackRock, an estimated $3.52M sold.

Based on aggregated 13F filings for Q2 2022.